当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第20期
编号:13289282
盐酸法舒地尔对动脉瘤性蛛网膜下腔出血介入栓塞术后Rho—激酶调控与脑血管痉挛的关系研究(5)
http://www.100md.com 2018年7月15日 《中国现代医生》 2018年第20期
     [15]娄四龙,戴勤弼,毛德强.Rho激酶抑制剂在外伤性蛛网膜下腔出血后脑血管痉挛的疗效研究[J].临床神经外科杂志,2009,(2):74-76.

    [16]封硕,李爱民,刘希光,李宁.Rho激酶抑制剂对动脉瘤性蛛网膜下腔出血后迟发性腦血管痉挛的疗效研究[J].临床神经外科杂志,2011,(3):122-123.

    [17]Asano T,Ikegaki I,Satoh S,et al.Mechansm of action of a novel antivasospasm drug,HA1077[J]. Journal of Pharmacology and Experimental Therapeutics,1987,241(3):1033-1041.

    [18]Li Q,Huang XJ,He W,et al.Neuroprotective potential of fasudil mesylate in brain ischemia reperfusion injury of rats[J].Cellular and Molecular Neurobiology,2009,29(2):169-180.

    [19]马景鑑,杨树源,魏伟岳,等. 盐酸法舒地尔治疗蛛网膜下腔出血所致脑血管痉挛的临床Ⅱ期试验研究[J].中华神经外科杂志,2006,22(1):36-40.

    [20]Nishiguchi M,Ono S,Iseda K,et al.Effect of vasodilation by milrinone,a phosphodiesterase III inhibitor,on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo:Effectiveness of cistemal injection of milrinone[J].Neurosurgery,2010,66(1):158-164.

    [21]Yamashita K,Kotani Y,Nakajima Y,et al.Fasudil,A Rho kinase(ROCK) inhibitor,protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons[J].Brain Research,2007,1154(1):215-224.

    (收稿日期:2018-01-02), 百拇医药(余丹枫 周格知 童民锋)
上一页1 2 3 4 5